1. Adhikari S, Gautam AR, Paudyal B, Sigdel KR, Basnyat B. 2019; Case Report: Gastric Mucormycosis- a rare but important differential diagnosis of upper gastrointestinal bleeding in an area of Helicobacter pylori endemicity. Wellcome Open Res. 4:5. DOI:
10.12688/wellcomeopenres.15026.1. PMID:
31131332. PMCID:
PMC6518441.
Article
3. Roden MM, Zaoutis TE, Buchanan WL, et al. 2005; Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 41:634–653. DOI:
10.1086/432579. PMID:
16080086.
Article
5. Riley TT, Muzny CA, Swiatlo E, Legendre DP. 2016; Breaking the mold: A review of mucormycosis and current pharmacological treatment options. Ann Pharmacother. 50:747–757. DOI:
10.1177/1060028016655425. PMID:
27307416.
6. Singh RP, Gupta N, Kaur T, Gupta A. 2021; Rare case of gastrointestinal mucormycosis with colonic perforation in an immunocompetent patient with COVID-19. BMJ Case Rep. 14:e244096. DOI:
10.1136/bcr-2021-244096. PMID:
34215642. PMCID:
PMC8256735.
Article
8. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. 2012; Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 54 Suppl 1:S23–34. DOI:
10.1093/cid/cir866. PMID:
22247442.
Article
10. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. 2009; Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 48:1743–1751. DOI:
10.1086/599105. PMID:
19435437. PMCID:
PMC2809216.
Article
12. Monte Junior ESD, Santos MELD, Ribeiro IB, et al. 2020; Rare and fatal gastrointestinal mucormycosis (zygomycosis) in a COVID-19 patient: a case report. Clin Endosc. 53:746–749. DOI:
10.5946/ce.2020.180. PMID:
33207116. PMCID:
PMC7719411.
Article